Abstract
Depression and schizophrenia are major psychiatric disorders. Recently it has been documented that these diseases are characterized by deficits and / or loss of neurons in specific brain regions. Nerve growth factor and brainderived neurotrophic factor are endogenous biological mediators involved in neuronal survival and plasticity of dopaminergic, cholinergic, and serotonergic neurons in the central nervous system. Structural, biochemical, and molecular findings led to the hypothesis that these molecules play a role in the pathophysiology of psychiatric disorders and suggested that alterations in expression of neurotrophic factors could be responsible for neural maldevelopment and disturbed neural plasticity both in young, adult and aged subjects. Studies aimed at understanding the mechanisms regulating these events might be an important line of research for analyzing the etiopathogenesis of psychiatric disorders and eventually identifying new methods for diagnosis and new therapeutic strategies.
Keywords: nerve growth factor, brain-derived neurotrophic factor, schizophrenia, depression, serotonergic neurons, neurotrophic factors, neural maldevelopment, neural plasticity, psychiatric disorders
Current Neuropharmacology
Title: Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models
Volume: 1 Issue: 2
Author(s): M. Fiore, F. Angelucci, L. Aloe, A. Iannitelli and J. Korf
Affiliation:
Keywords: nerve growth factor, brain-derived neurotrophic factor, schizophrenia, depression, serotonergic neurons, neurotrophic factors, neural maldevelopment, neural plasticity, psychiatric disorders
Abstract: Depression and schizophrenia are major psychiatric disorders. Recently it has been documented that these diseases are characterized by deficits and / or loss of neurons in specific brain regions. Nerve growth factor and brainderived neurotrophic factor are endogenous biological mediators involved in neuronal survival and plasticity of dopaminergic, cholinergic, and serotonergic neurons in the central nervous system. Structural, biochemical, and molecular findings led to the hypothesis that these molecules play a role in the pathophysiology of psychiatric disorders and suggested that alterations in expression of neurotrophic factors could be responsible for neural maldevelopment and disturbed neural plasticity both in young, adult and aged subjects. Studies aimed at understanding the mechanisms regulating these events might be an important line of research for analyzing the etiopathogenesis of psychiatric disorders and eventually identifying new methods for diagnosis and new therapeutic strategies.
Export Options
About this article
Cite this article as:
Fiore M., Angelucci F., Aloe L., Iannitelli A. and Korf J., Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models, Current Neuropharmacology 2003; 1 (2) . https://dx.doi.org/10.2174/1570159033477206
DOI https://dx.doi.org/10.2174/1570159033477206 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Protein disulfide isomerase and Nox: new partners in redox signaling
Current Pharmaceutical Design Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts
Current HIV Research Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease
Current Drug Targets Modulation of Apoptosis: New Opportunities for Drug Discovery to Treat Autoimmune Thyroiditis
Recent Patents on Inflammation & Allergy Drug Discovery Potential of Flavonoids as Anti-inflammatory Agents: Modulation of Pro- Inflammatory Gene Expression and Signal Transduction Pathways
Current Drug Metabolism Modulation of Host Cell Nucleocytoplasmic Trafficking During Picornavirus Infection
Infectious Disorders - Drug Targets Nicotinamide Phosphoribosyltransferase as a Target in Inflammation- Related Disorders
Current Topics in Medicinal Chemistry Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid
Current Alzheimer Research Emerging Synergisms Between Drugs and Physiologically-Patterned Weak Magnetic Fields: Implications for Neuropharmacology and the Human Population in the Twenty-First Century
Current Neuropharmacology Recent Patents in Toll-like Receptor Pathways and Relevance to Cancer
Recent Patents on Anti-Cancer Drug Discovery Highly Organized Nanostructures for Brain Drug Delivery - New Hope or Just a Fad?
CNS & Neurological Disorders - Drug Targets Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
Current Neuropharmacology Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus
Current Molecular Medicine Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles
Current Medicinal Chemistry Fibrinogen Signal Transduction as a Mediator and Therapeutic Target in Inflammation:Lessons from Multiple Sclerosis
Current Medicinal Chemistry Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects
CNS & Neurological Disorders - Drug Targets Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry